Obstructive sleep apnea and type 2 diabetes

Type 2 diabetes and obstructive sleep apnea (OSA) are diseases with high prevalence and major public health impact. There is evidence that regular snoring and OSA are independently associated with alterations in glucose metabolism. Thus, OSA might be a risk factor for the development of type 2 diabetes. Possible causes might be intermittent hypoxia and sleep fragmentation, which are typical features of OSA. OSA might also be a reason of ineffective treatment of type 2 diabetes. There is further evidence that the treatment of OSA by continuous positive airway pressure (CPAP) therapy might correct metabolic abnormalities in glucose metabolism. It is assumed that this depends on therapy compliance to CPAP. On the other hand, there are also hints in the literature that type 2 diabetes per se might induce sleep apnea, especially in patients with autonomic neuropathy. Pathophysiological considerations open up new insights into that problem. Based on the current scientific data, clinicians have to be aware of the relations between the two diseases, both from the sleep medical and the diabetological point of view. The paper summarizes the most important issues concerning the different associations of OSA and type 2 diabetes.

[1]  J. Manson,et al.  Snoring as a risk factor for type II diabetes mellitus: a prospective study. , 2002, American journal of epidemiology.

[2]  E. Tasali,et al.  Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. , 2008, Proceedings of the American Thoracic Society.

[3]  S. Redolfi,et al.  Autonomic Neuropathy Increases the Risk of Obstructive Sleep Apnea in Obese Diabetics , 2007, Respiration.

[4]  P. Giraud,et al.  Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome , 2003, European Respiratory Journal.

[5]  J. Roca,et al.  Ventilatory control in diabetes mellitus. , 1985, European journal of respiratory diseases.

[6]  G. Semenza,et al.  Ca2+/Calmodulin Kinase-dependent Activation of Hypoxia Inducible Factor 1 Transcriptional Activity in Cells Subjected to Intermittent Hypoxia* , 2005, Journal of Biological Chemistry.

[7]  J. Ficker,et al.  The Effect of Continuous Positive Airway Pressure Treatment on Insulin Sensitivity in Patients with Obstructive Sleep Apnoea Syndrome and Type 2 Diabetes , 2004, Respiration.

[8]  Terry Young,et al.  Association of sleep apnea and type II diabetes: a population-based study. , 2005, American journal of respiratory and critical care medicine.

[9]  G. Mitchell,et al.  Is there a link between intermittent hypoxia‐induced respiratory plasticity and obstructive sleep apnoea? , 2007, Experimental physiology.

[10]  J. Ficker,et al.  Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy , 1998, European Respiratory Journal.

[11]  E. van Cauter,et al.  Obstructive sleep apnea and type 2 diabetes: interacting epidemics. , 2008, Chest.

[12]  P. Cistulli,et al.  Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. , 1994, The Journal of clinical endocrinology and metabolism.

[13]  J. Ficker,et al.  Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. , 2004, American journal of respiratory and critical care medicine.

[14]  J. Stradling,et al.  Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes , 2007, Thorax.

[15]  M. Koziej,et al.  Respiratory responses to chemical stimulation in patients with obstructive sleep apnoea. , 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[16]  Min Zhang,et al.  Neurotransmitter mechanisms mediating low‐glucose signalling in cocultures and fresh tissue slices of rat carotid body , 2007, The Journal of physiology.

[17]  Harry Whitmore,et al.  Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. , 2010, American journal of respiratory and critical care medicine.

[18]  K. Miyamoto,et al.  Ventilatory and heart rate responses to hypoxia and hypercapnia in patients with diabetes mellitus. , 1989, Thorax.

[19]  R. Álvarez-Buylla,et al.  Carotid sinus receptors participate in glucose homeostasis. , 1988, Respiration physiology.

[20]  M. Macdermott,et al.  Upper airway EMG responses to acute hypoxia and asphyxia are impaired in streptozotocin-induced diabetic rats , 2003, Respiratory Physiology & Neurobiology.

[21]  D. Praticò,et al.  Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output. , 2004, American journal of respiratory and critical care medicine.

[22]  Obstructive sleep apnea syndrome: the effect of diabetes and autonomic neuropathy. , 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[23]  G. Semenza,et al.  Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Gislason,et al.  Sleep‐disordered breathing and glucose metabolism in hypertensive men: a population‐based study , 2001, Journal of internal medicine.

[25]  T. Yao,et al.  A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea , 2009, European Respiratory Journal.

[26]  E. Puxeddu,et al.  Ventilatory response to exercise in diabetic subjects with autonomic neuropathy. , 1996, Journal of applied physiology.

[27]  C. Liapis,et al.  An update on markers of carotid atherosclerosis in patients with Type 2 diabetes. , 2010, Biomarkers in medicine.

[28]  E. Puxeddu,et al.  Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. , 1997, Chest.

[29]  Guangping Li,et al.  Obstructive sleep apnea and the metabolic syndrome , 2012, Sleep and Breathing.

[30]  L. Provinciali,et al.  Cerebrovascular reactivity and hypercapnic respiratory drive in diabetic autonomic neuropathy. , 2001, Journal of applied physiology.

[31]  P. Bottini,et al.  Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy , 2003, European Respiratory Journal.

[32]  G. Can,et al.  Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance , 2007, Sleep and Breathing.

[33]  K. Kikuchi,et al.  Depression of peripheral chemosensitivity by a dopaminergic mechanism in patients with obstructive sleep apnoea syndrome. , 1999, The European respiratory journal.

[34]  D. Premkumar,et al.  L-type Ca(2+) channel activation regulates induction of c-fos transcription by hypoxia. , 2000, Journal of applied physiology.

[35]  Dorothy S. Lee,et al.  Progressive augmentation and ventilatory long‐term facilitation are enhanced in sleep apnoea patients and are mitigated by antioxidant administration , 2009, The Journal of physiology.

[36]  Naresh M Punjabi,et al.  Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. , 2008, Diabetes research and clinical practice.

[37]  John D. Mitchell,et al.  Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. , 2005, American journal of respiratory and critical care medicine.